Showing: 1 - 10 of 16 RESULTS

Vice President Venkaiah Naidu credits physical fitness and ‘desi’ food for his speedy recovery



Venkaiah Naidu wearing a suit and tie: He also expressed happiness at knowing that the other staff members who had contracted the disease in the Vice President Secretariat had also recovered from Coronavirus.


© Provided by The Financial Express
He also expressed happiness at knowing that the other staff members who had contracted the disease in the Vice President Secretariat had also recovered from Coronavirus.

Vice President Venkaiah Naidu has credited his speedy recovery from Coronavirus to his physical fitness, mental tenacity and desi food. In a long blog posted from his facebook account, the Vice President said that he firmly believed that it was his physical fitness and strict adherence to traditional food which ensured his recovery from the disease despite his old age and him being a diabetes patient.

“I could overcome COVID-19 infection because of my physical fitness, mental tenacity, regular physical exercise like walking and yoga, apart from eating only desi (traditional) food,” the Vice President wrote in his blog. He also said that he always preferred to eat traditional food and continued the practice during the quarantine period as well.

Naidu also urged his followers to include some form of physical exercise in their daily regimen like walking or Yoga in addition to advising against the consumption of junk food. Being a workaholic, Naidu, who had been under home quarantine for about a fortnight, kept busy with reading loads of books on India’s freedom struggle. A regular writer for a number of India’s dailies, Naidu also posted two articles every week on the same issue on facebook to apprise his followers of the role of many unsung heroes of the independence movement.

VP Naidu had contracted the disease on September 29 after which he went under home quarantine. After conducting the RT-PCR test, the team of doctors attending the Vice President declared him recovered after his report came negative on October 12. Naidu in his blog thanked the team of doctors and other staff members for taking care of him. He also expressed happiness at knowing that the other staff members who had contracted the disease in the Vice President Secretariat had also recovered from Coronavirus.

Source Article

Trump’s rapid recovery from Covid-19, while welcome, ‘amplifies’ public misunderstanding of disease

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a House Select Subcommittee on the Coronavirus Crisis hearing in Washington, D.C.

Erin Scot | Pool | Reuters

Health officials have struggled to convey the seriousness of Covid-19 to many Americans. President Trump’s rapid recovery from the disease, while welcome by all, makes the challenge even more difficult, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases acknowledged.

Trump’s quick bounce-back from his infection will likely underscore the mistaken belief some people have that the disease does not present significant health risks, Fauci said in an interview with STAT.

“We’re all glad that the president of the United States did not suffer any significant consequences of it,” Fauci said. “But … because he is such a visible figure, it amplifies some of that misunderstanding that people have that it’s a benign disease and nobody has anything to worry about.”

More from STAT News:

The wide range of clinical manifestations of the disease — some people experience no symptoms, while others have everything from flu-like symptoms to life-threatening and even fatal pneumonia and blood clots — makes conveying the dangerousness of Covid-19 incredibly challenging, he said.

“It’s just a lot of understandable mixed signals, that it’s either serious or it’s not serious. It’s deadly or it’s not deadly. To me, that’s been the bane of trying to get a message across to people,” he said.

“It’s a problem that goes well beyond the president’s illness.”

Trump, who was considered at high risk of having severe Covid-19 because of his age, weight, and sex, was hospitalized for four days earlier this month after testing positive for the SARS-CoV-2 virus, which causes Covid-19. First lady Melania Trump also tested positive for the virus; White House doctors described her case as milder than the president’s. She did not need to be hospitalized.

The president required supplemental oxygen on at least two occasions before he was taken by helicopter to Walter Reed National Military Medical Center on Oct. 2. In the four days he was there, Trump was treated with an experimental antibody cocktail, the antiviral drug remdesivir, and the steroid dexamethasone.

He has since resumed work, holding a rally Monday in Florida where he declared himself to be immune to Covid-19, and heading to Iowa, a Covid-19 hot spot, on Wednesday. He has also tweeted that people should not let fear of the disease run their lives, asserting that he feels better now than he did 20 years ago.

Trump also continues to insist the virus will soon disappear, even though daily infection numbers are climbing in most parts of the country. So far in the pandemic, more than 7.8 million Americans have been infected and more than 215,000 have died.

Since movement restrictions were eased in the summer, many cases have occurred in young adults, a demographic group that rarely dies from the disease. Fauci and others have struggled to find a way to persuade people

Aiming to hit top fitness levels post Covid recovery, says Surender Kumar

(MENAFN – IANS)

New Delhi, Oct 12 (IANS) Defender Surender Kumar, who was one of the six players of the Indian men’s hockey team too have tested positive for Covid-19 in August, has revealed that the entire period was mentally very challenging for him.

“I would often tell myself that so many people around the globe have battled this virus including top sports people and have come out of it. It was a difficult phase but I am really grateful for the kind of support system we had from Hockey India and SAI who made every effort to get us the best treatment,” Kumar said.

Unlike his other compatriots who had tested positive and recovered, Kumar had developed venous thrombosis, a condition in which there are blood clots. It is one of the many complications related to Covid-19 recovery phase.

“Again, I am grateful to Hockey India and SAI for ensuring my recovery is closely monitored. I get my routine check-ups done regularly. We also have a doctor on campus who I can consult in case of any discomfort. I feel we are just fortunate to have this kind of support. My focus now is on hockey,” he said.

“The team coaching staff ensured we were in a good space mentally for that entire period of two-three weeks where we were in the hospital followed by mandatory isolation,” added the defender from Karnal Haryana who was part of the Indian Team for Rio Olympics in 2016.

Having returned to the pitch in mid-September and join the rest of the team, his main aim is to gain full-fitness.

“I am happy to be back to regular schedule with the rest of the core group. Initially, chief coach would emphasis on taking it slow and not exerting too much even though we would feel no discomfort in pushing ourselves. It’s now been over three weeks since I have returned to training. I am feeling good and aiming to hit top fitness levels,” he said.

–IANS

aak/

MENAFN1210202002310000ID1100941496


Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Source Article

Aiming to Hit Top Fitness Levels Post Covid-19 Recovery, Says Surender Kumar

Defender Surender Kumar, who was one of the six players of the Indian men’s hockey team too have tested positive for Covid-19 in August, has revealed that the entire period was mentally very challenging for him.

“I would often tell myself that so many people around the globe have battled this virus including top sports people and have come out of it. It was a difficult phase but I am really grateful for the kind of support system we had from Hockey India and SAI who made every effort to get us the best treatment,” Kumar said.

Unlike his other compatriots who had tested positive and recovered, Kumar had developed venous thrombosis, a condition in which there are blood clots. It is one of the many complications related to Covid-19 recovery phase.

“Again, I am grateful to Hockey India and SAI for ensuring my recovery is closely monitored. I get my routine check-ups done regularly. We also have a doctor on campus who I can consult in case of any discomfort. I feel we are just fortunate to have this kind of support. My focus now is on hockey,” he said.

“The team coaching staff ensured we were in a good space mentally for that entire period of two-three weeks where we were in the hospital followed by mandatory isolation,” added the defender from Karnal Haryana who was part of the Indian Team for Rio Olympics in 2016.

Having returned to the pitch in mid-September and join the rest of the team, his main aim is to gain full-fitness.

“I am happy to be back to regular schedule with the rest of the core group. Initially, chief coach would emphasis on taking it slow and not exerting too much even though we would feel no discomfort in pushing ourselves. It’s now been over three weeks since I have returned to training. I am feeling good and aiming to hit top fitness levels,” he said.

Source Article

Arm squeezes with blood pressure cuffs may help stroke recovery

After administering clot-busting drugs to treat a stroke, using blood pressure cuffs to squeeze each arm might aid recovery, a new, small Chinese study suggests.

In the technique — called remote ischemic post-conditioning — the flow of oxygen-rich blood is repeatedly interrupted and restored using blood pressure cuffs on the arms. Earlier studies have found that the technique may prevent tissue damage by helping the body handle changes in blood flow and the damage that may occur from a stroke, researchers say.

“The findings show a promising future prospect of remote ischemic post-conditioning and have important clinical implications,” said researcher Dr. Guo-liang Li, of First Affiliated Hospital of Xi’an and Jiaotong University in Xi’an, China.

“As we all know, the therapy has a lot of advantages,” he said, calling it noninvasive, easy-to-use, cost-effective and safe.

Even though clot-busting drugs have saved many stroke patients, 32% do not have a favorable outcome. This is partly because blood flow is not completely restored and vessels can clot even after clot-busting drugs are given, Li said.

“Remote ischemic post-conditioning can be a complementary treatment that can improve the prognosis in stroke patients,” he said.

This study was done in China, but Li said the technique has also been studied in the United Kingdom, France and Denmark.

For the study, Li’s team randomly assigned 68 people (average age: 65) who suffered a stroke. All were treated within 4.5 hours with a medication that dissolves blood clots called tPA. Half also received ischemic post-conditioning therapy.

Over an average of 11 days, post-conditioning participants wore blood pressure cuffs on both arms for 40 minutes, alternating cycles of inflation for five minutes and deflation for three minutes. Treatments were done twice a day.

Stroke recovery was gauged on a scale of no symptoms no significant disability despite some symptoms or slight disability. People who had no symptoms after three months were considered to have had a favorable recovery.

Seventy-two percent of those who wore the blood pressure cuff had a favorable recovery, compared with 50% of those who didn’t, the researchers found. These findings remained significant even after taking into account age, stroke severity and other factors.

During the trial, two people dropped out — one because the cuffs caused skin redness and the other because the pressure applied during the procedure was uncomfortable. Researchers don’t know how long the treatment is needed to be most effective.

They caution that ischemic post-conditioning is still experimental and isn’t something that should be tried on recovering stroke patients at home.

“In the future, more studies are needed to confirm that the combined therapy of clot-busting drugs and remote ischemic post-conditioning is safe and effective in much larger groups of people before this experimental therapy can be performed at home,” Li said.

Dr. Larry Goldstein, chairman of the Department of Neurology at the University of Kentucky, reviewed the findings.

“This single hospital study was aimed at determining whether the technique might be helpful in improving outcomes of patients with stroke

Trump hails experimental treatment for his virus recovery, without providing evidence

President Donald Trump credited an experimental drug treatment with helping his recovery from Covid-19 and suggested his diagnosis could be a “blessing in disguise” in the nation’s battle against the pandemic. But there is no way for the president or his doctors to know whether the drug had any effect.

In a new White House video posted Wednesday evening, Trump said his illness had shed light on an experimental antibody cocktail that he tied to his improved condition. Seemingly sensitive to the fact that his treatment course has been far more comprehensive than the care received by average Americans, he promised to swiftly get the drug approved for broader use — and distribute it for free — even though he does not have the power to order that himself.

“I want everybody to be given the same treatment as your president, because I feel great,” Trump said in a video from the Rose Garden. “I feel, like, perfect.”

Still, questions continue to swirl about the trajectory of Trump’s recovery and when he might be able to return to normal activities, including campaigning, less than four weeks before Election Day. The video marked Trump’s first appearance before a camera — albeit a White House-operated one — in nearly two days. The White House has released only limited details about his condition and treatment, leading to questions about what lies ahead for Trump.

Trump received an experimental antiviral cocktail made by Regeneron through a “compassionate use” exemption, a recognition of the above-and-beyond standard of care he receives as president. The safety and effectiveness of the drug have not yet been proven. And there is no way for the president or his doctors to know that the drug had any effect. Most people recover from Covid-19.

It’s not the first time the president has trumpeted an unproven treatment. He spent months painting the anti-malarial drug hydroxychloroquine as a miracle treatment for the virus — taking a preventative course himself — even though experts have said it is not effective against Covid-19.

Trump hailed the Regeneron cocktail even as drugmaker Eli Lilly moves forward with its own similar treatment.

Eli Lilly formally asked the Food and Drug Administration on Wednesday to allow emergency use of its experimental antibody-based on early results suggesting it reduces symptoms. There is no timetable for the FDA to make a decision, though the agency has moved on such applications within weeks.

Lilly says it could supply as many as 1 million doses of its therapy in the final quarter of 2020, with 100,000 available in October. Regeneron confirms it has also applied for emergency authorization, and said Wednesday it has enough doses for approximately 50,000 patients, and expects 300,000 available within the next few months.

The company said this advance production would allow the treatment to be distributed “immediately” if it were authorized by the FDA.

In the video, Trump continued to play down the threat of the virus, promising those who are ill that they’re going to “get

Trump hails experimental treatment for his virus recovery

WASHINGTON (AP) — President Donald Trump credited an experimental drug treatment with helping his recovery from COVID-19 and suggested his diagnosis could be a “blessing in disguise” in the nation’s battle against the pandemic. But there is no way for the president or his doctors to know whether the drug had any effect.

In a new White House video posted Wednesday evening, Trump said his illness had shed light on an experimental antibody cocktail that he tied to his improved condition. Seemingly sensitive to the fact that his treatment course has been far more comprehensive than the care received by average Americans, he promised to swiftly get the drug approved for broader use — and distribute it for free — even though he does not have the power to order that himself.

“I want everybody to be given the same treatment as your president, because I feel great,” Trump said in a video from the Rose Garden. “I feel, like, perfect.”

Still, questions continue to swirl about the trajectory of Trump’s recovery and when he might be able to return to normal activities, including campaigning, less than four weeks before Election Day. The video marked Trump’s first appearance before a camera — albeit a White House-operated one —in nearly two days. The White House has released only limited details about his condition and treatment, leading to questions about what lies ahead for Trump.

Trump received an experimental antiviral cocktail made by Regeneron through a “compassionate use” exemption, a recognition of the above-and-beyond standard of care he receives as president. The safety and effectiveness of the drug have not yet been proven. And there is no way for the president or his doctors to know that the drug had any effect. Most people recover from COVID-19.

It’s not the first time the president has trumpeted an unproven treatment. He spent months painting the anti-malarial drug hydroxychloroquine as a miracle treatment for the virus — taking a preventative course himself — even though experts have said it is not effective against COVID-19.

Trump hailed the Regeneron cocktail even as drugmaker Eli Lilly moves forward with its own similar treatment.

Eli Lilly formally asked the Food and Drug Administration on Wednesday to allow emergency use of its experimental antibody based on early results suggesting it reduces symptoms. There is no timetable for the FDA to make a decision, though the agency has moved on such applications within weeks.

Lilly says it could supply as many as 1 million doses of its therapy in the final quarter of 2020, with 100,000 available in October. Regeneron confirms it has also applied for emergency authorization, and said Wednesday it has enough doses for approximately 50,000 patients, and expects 300,000 available within the next few months.

The company said this advance production would allow the treatment to be distributed “immediately” if it were authorized by the FDA.

In the video, Trump continued to play down the threat of the virus, promising those who are ill

Trump Hails Experimental Treatment for His Virus Recovery | Washington, D.C. News

By AAMER MADHANI, JILL COLVIN and MATTHEW PERRONE, Associated Press

WASHINGTON (AP) — President Donald Trump credited an experimental drug treatment with helping his recovery from COVID-19 and suggested his diagnosis could be a “blessing in disguise” in the nation’s battle against the pandemic. But there is no way for the president or his doctors to know whether the drug had any effect.

In a new White House video posted Wednesday evening, Trump said his illness had shed light on an experimental antibody cocktail that he tied to his improved condition. Seemingly sensitive to the fact that his treatment course has been far more comprehensive than the care received by average Americans, he promised to swiftly get the drug approved for broader use — and distribute it for free — even though he does not have the power to order that himself.

“I want everybody to be given the same treatment as your president, because I feel great,” Trump said in a video from the Rose Garden. “I feel, like, perfect.”

Still, questions continue to swirl about the trajectory of Trump’s recovery and when he might be able to return to normal activities, including campaigning, less than four weeks before Election Day. The video marked Trump’s first appearance before a camera — albeit a White House-operated one —in nearly two days. The White House has released only limited details about his condition and treatment, leading to questions about what lies ahead for Trump.

Trump received an experimental antiviral cocktail made by Regeneron through a “compassionate use” exemption, a recognition of the above-and-beyond standard of care he receives as president. The safety and effectiveness of the drug have not yet been proven. And there is no way for the president or his doctors to know that the drug had any effect. Most people recover from COVID-19.

It’s not the first time the president has trumpeted an unproven treatment. He spent months painting the anti-malarial drug hydroxychloroquine as a miracle treatment for the virus — taking a preventative course himself — even though experts have said it is not effective against COVID-19.

Trump hailed the Regeneron cocktail even as drugmaker Eli Lilly moves forward with its own similar treatment.

Eli Lilly formally asked the Food and Drug Administration on Wednesday to allow emergency use of its experimental antibody based on early results suggesting it reduces symptoms. There is no timetable for the FDA to make a decision, though the agency has moved on such applications within weeks.

Lilly says it could supply as many as 1 million doses of its therapy in the final quarter of 2020, with 100,000 available in October. Regeneron confirms it has also applied for emergency authorization, and said Wednesday it has enough doses for approximately 50,000 patients, and expects 300,000 available within the next few months.

The company said this advance production would allow the treatment to be distributed “immediately” if it were authorized by the FDA.

In the video, Trump continued to play down the threat

Alcon to Showcase Innovations at #Academy20 that Support Recovery and Growth for Eye Care Practices

  • Clinical findings to be presented on PRECISION1® daily disposable contact lenses and Systane® family of dry eye products

  • Meeting attendees will have opportunity to get an exclusive demo of MARLO, Alcon’s new digital platform

  • Interactive virtual Alcon booth will offer clinical education learning lab, product innovations, an OD-to-OD live theater, a COVID-19 practice response section and more

Alcon, the global leader in eye care, will highlight leading innovations and clinical research at the 2020 American Academy of Optometry (the Academy or #Academy20) meeting taking place virtually from October 7 – 22, 2020. The company’s robust virtual program will feature updates on its most important innovations, including PRECISION1® one-day contact lenses, Systane® iLux® MGD Treatment System and digital platform MARLO, as well as 23 scientific presentations on a range of technologies.

“Now more than ever, there’s an increasing need to bolster practice growth and deliver on unmet patient needs during these challenging times,” said Sean Clark, VP/General Manager, U.S. Vision Care, Alcon. “Throughout the COVID-19 pandemic, Alcon has doubled down on our commitment to support Eye Care Professionals by providing tools, resources and programs to support their practices and their patients. We believe the innovations we’re bringing to this year’s Academy meeting will help our partners get back to business so we can continue helping people See Brilliantly together.”

Alcon’s virtual booth will feature a live theater offering OD-to-OD education and Q&A sessions; an in-depth learning lab; resources for Eye Care Professionals (ECPs) to help their practices recover following COVID-19 shutdowns; product innovation showcases; direct support from Alcon’s medical affairs team; a fun, interactive game center to get the full event experience at home; and, more.

Clinical Data Highlights Key Benefits of PRECISION1 Contact Lenses

Clinical findings will be presented at #Academy20, highlighting key attributes of Alcon’s latest contact lens innovation, PRECISION1. Specifically, data presented at the meeting will look at the lens’ overall performance, efficacy during digital device use and the clinical performance of a forthcoming toric version of PRECISION1. PRECISION1 meeting highlights include:

  • Friday, October 9

    • Paper Presentation: Clinical Comparison of Verofilcon A and Etafilcon A Daily Disposable Contact Lenses. Presented by Dr. Jason Miller, 3:15 – 3:30 p.m. ET

    • Poster Presentation: The subjective response to Verofilcon A Daily Disposable Contact Lenses During Extensive Digital Device Use. Presented by Dr. Marc Schulze, 4:00 – 6:00 p.m. ET

    • Poster Presentation: Clinical Performance of Verofilcon A Toric Daily Disposable Silicone Hydrogel Contact Lenses. Presented by Dr. Wilson Movic, 4:00 – 6:00 p.m. ET

    • Poster Presentation: Use of Likert Questionnaires to Compare Subjective Performance of Two Daily Disposable Soft Contact Lenses. Presented by Dr. Jason Miller, 4:00 – 6:00 p.m. ET

  • Friday, October 16

    • Lunch Symposium: The Next Big Thing, featuring PRECISION1. Guest Speaker Dr. Pam Lowe, 12:00 – 1:00 p.m. ET

Broadened U.S. Availability of MARLO Helps ODs Stay Connected to their Patients

Following a successful pilot, Alcon announced in August the broader U.S. availability of its innovative MARLO

Trump enters ‘uncharted territory,’ returning to White House at fraught moment in his recovery

The president returns to the White House at a fraught moment in his recovery — before he has seemingly escaped a period when some patients are known to crash.

“The problem with covid-19 is that people’s condition can deteriorate rapidly, even after days of stability,” said Harlan Krumholz, a cardiologist and health-care researcher at Yale University and Yale New Haven Hospital. “And so we are more accustomed to be cautious with people with high risk.”

The president has received care accessible to few other Americans. He was given a brew of laboratory-made antibodies that fewer than 10 other patients have received outside of clinical trials. And for him, returning home means arriving at a place that can be adapted to cater to his needs, Krumholz and others said.

Jonathan Reiner, a George Washington University Hospital cardiologist, said that in an emergency, the White House medical unit “can do what an emergency room can do in the first 15 minutes” — someone could be resuscitated and stabilized during a heart attack, for example, and then transferred to a hospital. Still for ongoing treatment, he said, it would be wise for Trump to remain hospitalized.

“It makes zero sense to move him from Walter Reed,” Reiner said.

At a Monday news conference, White House physician Sean P. Conley said doctors were “cautiously optimistic and on guard” about Trump’s discharge. But he said the benefits of returning to the White House outweighed the risks.

“Every day a patient stays in the hospital unnecessarily is a risk to themselves,” Conley said. “And right now there’s nothing that’s being done upstairs here that we can’t safely conduct down home.”

But Conley acknowledged that the medical team is in “uncharted territory” with the mix of medications the president has been given and that the dangerous period for the infection is not over. He’s “looking to this weekend” for assurance that Trump has cleared rough waters.

“If we can get through to Monday” of next week, he said, doctors will “take that final deep sigh of relief.”

Conley declined for the third briefing in a row to answer additional questions about X-rays and other images taken of Trump’s lungs, and about other key data, such as when he last received a negative coronavirus test before falling ill. Instead, Conley emphasized symptoms the president was not experiencing: A “slight cough” was gone. There were never complaints of muscle aches. And fever-reducing drugs had not been deployed for at least 72 hours.

“He’s up and back to his old self, predominantly,” Conley said.

In the White House, Trump’s doctors will be vigilant for sudden changes, specialists predicted.

“You would want to be prepared to take care of any sudden unanticipated or very concerning event,” said Jeanne Marrazzo, an infectious-diseases expert at the University of Alabama at Birmingham. The biggest risk, she said, would be the sudden onset of acute respiratory distress syndrome, which sometimes occurs with covid-19. Patients’ lungs fill with fluid, and they can’t breathe on their own.